Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-21 · accession 0001846487-24-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-22 | 2024-05-21 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $61.61 | -2,000 | 83.3K | -2% | -$123.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-21 | S | D | 2,000 | $61.61 | 83,277 | D | — | — |